The life sciences sector secured $1.8 billion in venture capital investments during the second quarter, a 26% increase over the same period in 2012, according to MoneyTree. The number of deals fell 7%. “While hurdles remain for life science funding compared with technology, seeing VCs investing in promising biotech sectors shows the continued strength of this industry.
